Avenir Wellness Solutions, Inc. (AVRW)
0.0002
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Avenir Wellness Solutions Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.30M |
| June 30, 2024 | 13.04M |
| March 31, 2024 | 12.96M |
| December 31, 2023 | 12.49M |
| September 30, 2023 | 12.79M |
| June 30, 2023 | 11.58M |
| March 31, 2023 | 12.30M |
| December 31, 2022 | 13.96M |
| September 30, 2022 | 15.14M |
| June 30, 2022 | 26.43M |
| March 31, 2022 | 25.22M |
| December 31, 2021 | 24.46M |
| September 30, 2021 | 23.29M |
| June 30, 2021 | 23.24M |
| March 31, 2021 | 24.32M |
| December 31, 2020 | 25.08M |
| September 30, 2020 | 5.442M |
| June 30, 2020 | 3.436M |
| March 31, 2020 | 14.10M |
| Date | Value |
|---|---|
| December 31, 2019 | 18.95M |
| September 30, 2019 | 20.67M |
| June 30, 2019 | 25.25M |
| March 31, 2019 | 5.456M |
| December 31, 2018 | 8.552M |
| September 30, 2018 | 8.166M |
| June 30, 2018 | 6.473M |
| March 31, 2018 | 5.789M |
| December 31, 2017 | 4.089M |
| September 30, 2017 | 3.273M |
| June 30, 2017 | 2.429M |
| March 31, 2017 | 1.147M |
| December 31, 2016 | 1.118M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 0.004M |
| December 31, 2015 | 0.004M |
| September 30, 2015 | 0.0053M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aeolus Pharmaceuticals, Inc. | -- |
| Bespoke Extracts, Inc. | 2.891M |
| Bright Green Corp. | -- |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |